Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,525-10,536 of 23,847
Drug study icon
CompletedNCT00946348

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In Lebanon
Schizophrenia, AddictionDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia, Addiction
Other study type icon
TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.

In Bron
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Drug study icon
CompletedNCT04228965

Cannabis and Tobacco Co-use Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Charleston
AddictionDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT03948074

Cannabis For Cancer-Related Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
AnxietyDrugOver 19 Years
Countries
Canada
Sponsor
Pippa Hawley
Condition
Anxiety
Drug study icon
CompletedNCT04230460

Cannabis Impairment Detection Application (CIDA)

This summary needs review. Please check the official study record and contact the research team for details.

In Iowa City
AddictionDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Advanced Brain Monitoring, Inc.
Condition
Addiction
Drug study icon
CompletedNCT01964404

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Lebanon
Schizophrenia, AddictionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia, Addiction
Drug study icon
CompletedNCT02655692

CAP-Ketamine for Antidepressant Resistant PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including West Haven
PTSDDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Drug study icon
CompletedNCT00203567

Carbamazepine Extended-Release for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Tuscaloosa
Bipolarity, DepressionDrugFrom 19 Years to 65 Years
Countries
United States
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.